BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/18/2025 9:39:02 AM | Browse: 56 | Download: 66
 |
Received |
|
2025-01-05 15:02 |
|
Peer-Review Started |
|
2025-01-05 15:02 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-13 22:16 |
|
Revised |
|
2025-02-22 08:06 |
|
Second Decision |
|
2025-03-26 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-03-26 05:48 |
|
Articles in Press |
|
2025-03-26 05:48 |
|
Publication Fee Transferred |
|
2025-02-26 02:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-14 03:20 |
|
Publish the Manuscript Online |
|
2025-04-18 07:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun-Jie Liu, Mi Zhou, Tong Yuan, Zhi-Yong Huang and Zun-Yi Zhang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zun-Yi Zhang, Associate Professor, MD, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China. zunyizhangtjmu@163.com |
| Key Words |
Intrahepatic cholangiocarcinoma; Conversion treatment; Downstaging; Combination therapy; Chemotherapy; Immunotherapy; Locoregional therapies |
| Core Tip |
The conversion treatment for unresectable intrahepatic cholangiocarcinoma (ICC) can reduce tumor burden and enhance the likelihood of surgical resection. Chemotherapy is still the base treatment for advanced ICC. However, locoregional therapies and systemic therapies are promising treatment strategies for advanced ICC, aiming to enhance tumor response and improve patient outcomes. Achieving an adequate future liver remnant is crucial to prevent posthepatectomy liver failure; techniques are being investigated to enhance future liver remnant and improve outcomes in patients with advanced ICC. |
| Publish Date |
2025-04-18 07:43 |
| Citation |
<p>Liu JJ, Zhou M, Yuan T, Huang ZY, Zhang ZY. Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges. <i>World J Gastroenterol</i> 2025; 31(15): 104901</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i15/104901.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i15.104901 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
